2019 AVBCC Summit Agenda

AVBCC

October 16-18, 2019

New York Athletic Club, New York, NY

Coming Soon!

The 2019 AVBCC Summit agenda is not available at this time. Please check back again soon.


Download 2018 Summit Agenda

2018 Summit Agenda

Day 1 – Tuesday, October 30, 2018

6:30 am – 7:30 am Conference Registration
6:30 am – 7:30 am Networking Breakfast
7:30 am Opening Remarks and Greeting
  • Burt Zweigenhaft, Co-Chair, AVBCC
  • Michael Kolodziej, Co-Chair, AVBCC
  • William McGivney, Co-Chair, AVBCC
  • Jayson Slotnik, Co-Chair, AVBCC
7:30 am – 8:30 am Keynote
8:30 am – 9:15 am Tomorrow’s Cancer Care: A Government Policy Perspective
  • Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
  • Faculty:
    • Randy Burkholder, VP, Policy and Research, PhRMA
    • Crystal Kuntz, VP, Healthcare Policy and Research, Biotechnology Innovation Organization (BIO)
    • A. Mark Fendrick, MD, Director, Center for Value-Based Insurance Design, University of Michigan
9:15 am – 10:00 am Tomorrow’s Cancer Care: An Insurance Payer’s Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Steve Peskin, MD, MBA, FACP, Executive Medical Director, Population Health, Horizon BCBS
    • William (Bill) Winkenwerder, Jr, MD, Chairman, CitiusTech and former CEO, Highmark Health
10:00 am – 10:45 am Tomorrow’s Cancer Care: A Center of Excellence Perspective
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Al Benson III, MD, FACP, FASCO, Northwestern Medicine
    • Maurie Markman, MD, President, CTCA Medicine & Science
10:45 am – 11:15 am Tomorrow’s Cancer Care: The Community-Based Care Perspective
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Barry Brooks, MD, Medical Director, US Oncology
    • Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers
    • Jeffrey Scott, MD, CMO, Integra Connect, LLC
11:15 am – 12:00 pm Keynote: Cancer Drug Trend Report
Doug Long, VP, Industry Relations, IQVIA
12:00 pm – 12:45 pm Keynote: Cancer Care into the Future
Greg Simon, President, Biden Cancer Initiative
12:45 pm – 1:30 pm
Tomorrow’s Cancer Care: The Employer Perspective
  • Moderator: F. Randy Vogenberg, PhD, RPh, Principal, Institute for Integrated Healthcare (IIH)
  • Faculty:
    • Michael Thompson, President & CEO, National Alliance of Healthcare Purchaser Coalitions
    • Patricia Goldsmith, CEO, CancerCare
Optimizing Patient Services: Solutions in Cancer Care
  • Moderator: Douglas Bock, Partner, Archbow Consulting
  • Faculty:
    • Sumner Madden, Senior Director, Access360, AstraZeneca
    • Michael Fitzgibbons, CEO, Claritas Rx
    • Tara Herington, RN, VP, Sonexus™ Access and Patient Support, Cardinal Health
1:30 pm – 2:15 pm Tomorrow’s Cancer Care: A Pharma Perspective
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Axel Hoos, MD, SVP, Head, Oncology R&D, GlaxoSmithKline
    • Kim Blackwell, MD, VP, Early Phase Development & Immuno-oncology, Eli Lilly & Co
Track 1:
CLINICAL
Track 2:
TECHNOLOGY
Track 3:
SUPPLY CHAIN
Track 4:
BUSINESS
Track 5:
CONTRACTING
Track 6:
SPECIALTY PHARMACY
Track 7:
CARE MANAGEMENT
Track 8:
INDUSTRY SURVEY
2:15 pm – 3:15 pm
BREAKOUT 1: CLINICAL
Cell-Based Immunotherapies
  • Moderator: Morrie Ruffin, CEO, Adjuvant Partners
  • Faculty:
    • Alfred Slanetz, PhD, CEO, Genius Biotechnology
    • Kim Noonan, PhD, Founder & CSO, WindMIL Therapeutics
    • Sean Tunis, MD, MSc, Founder & CEO, Center for Medical Technology Policy
    • Kimberly Freeman, VP, Global Commercial Strategy, Adaptimmune
    • Greg Russotti, PhD, VP, Cell Therapy Technical Development, Celgene Corporation
BREAKOUT 2: TECHNOLOGY
Applying Machine Learning to Aid Decision-Making in Cancer Treatment
  • Moderator: Annatasiah Mhaka, PhD, Senior Advisor, Adjuvant Partners, and Co-Founder, Alliance for Artificial Intelligence In Healthcare
  • Faculty:
    • George Daneker, MD, CMO, Cancer Treatment Centers of America
    • William A. Flood, MD, MSc, CMO, eviti NantHealth
    • Robert S. Miller, MD, VP & Medical Director, CancerLinQ, American Society of Clinical Oncology
    • Rohit Borker, PhD, VP & Head, Health Economics and Outcomes Research, US Oncology: Novartis Pharmaceuticals Corporation
    • Ben Newton, PhD, Global Head, GE Healthcare Life Sciences Molecular Imaging
BREAKOUT 3: SUPPLY CHAIN
Oncology Supply Chain
  • Moderator: Kevin Cast, Partner, Archbow Consulting
  • Faculty:
    • Randy Maloziec, VP, Bio Services, US Bioservices, an AmerisourceBergen Specialty Company
    • Lisa Harrison, Senior Director, Pharmacy and Clinical Services, ION Solutions
    • Nick Calla, RPh, Esq, VP, Industry Relations, Cardinal Health Specialty Solutions
BREAKOUT 4: CARE MANAGEMENT
The Patient Voice and Advocate Perspective
  • Moderator: Robert Goldberg, PhD, CEO, Thrive HealthRx
  • Faculty:
    • Daniel Klein, President & CEO, Patient Access Network Foundation
    • Clorinda Walley, CEO, Chronic Disease Fund
    • Patricia Goldsmith, CEO, CancerCare
    • Elizabeth Franklin, LGSW, ACSW, Executive Director, Cancer Policy Institute, Cancer Support Community
3:15 pm – 4:15 pm
BREAKOUT 5: SUPPLY CHAIN
CAR-T Pipeline and Market Access
  • Moderator: Morrie Ruffin, CEO, Adjuvant Partners
  • Faculty:
    • Amy DuRoss, MBA, Co-Founder & CEO, Vineti
    • Joel Brill, MD, CMO, Predictive Health, LLC
    • Bob Charles, BS, MBA, Founder/Principal The GeneriSys Company
    • Greta Stone, Deputy VP, Policy & Research, PhRMA
BREAKOUT 6: TECHNOLOGY
Big Data: “The New Oil”
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Marcus Neubauer, MD, VP & Medical Director, Value-Based Reimbursement, McKesson Specialty Health
    • Susan Weidner, MS, SVP, IntrinsiQ Specialty Solutions, AmerisourceBergen
    • Ash Malik, President, Life Sciences Division, Integra Connect, LLC
BREAKOUT 7: CONTRACTING
Update on the CMS Oncology Care Model and Other Oncology Alternative Payment Models
  • Moderator: Pamela Pelizzari, MPH, Healthcare Consultant, Milliman
  • Faculty:
    • Michael Ruiz de Somocurcio, MBA, VP, Payer & Provider Collaboration, Regional Cancer Care Associates
    • Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennsylvania State University
BREAKOUT 8: BUSINESS
The Burden of Cancer Care: Financial & Nonfinancial Costs Associated with Cancer Diagnosis & Treatment
  • Moderator: Christine Ferro, CHFP, Healthcare Analytics Consultant, Milliman
  • Faculty: Danielle Bubnis, Senior Director, Advocacy, Leukemia & Lymphoma Society
4:15 pm – 5:00 pm
BREAKOUT 9: CLINICAL
Genomics and Personalized Medicine
  • Moderator: Louis Jacques, MD, Chief Clinical Officer, ADVI Health LLC
  • Faculty:
    • Stan Skrzypczak, VP, Corporate Development & Reimbursement, Guardant Health
    • Edward Abrahams, PhD, President, Personalized Medicine Coalition
    • David Spetzler, MS, PhD, MBA, President & CSO, Caris Life Sciences
    • John Simmons, PhD, Director, Translational Science and Diagnostics, PGDx
    • Rachel Anhorn, PharmD, Director, Payer Policy and Health Outcomes, Foundation Medicine
BREAKOUT 10: CONTRACTING
Value-Based Oncology Care
  • Moderator: Jude Gallagher, PA, MBA, Former Director, Complex Clinical Care Strategy, Humana
  • Faculty:
    • Brian Bourbeau, MBA, LSSBB, Associate Director, Business Metrics and Analysis, American Society of Clinical Oncology (ASCO)
    • Virginia Calega, MD, MBA, FACP, VP, Medical Management & Policy, Independence Blue Cross
    • Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennsylvania State University
    • Ed Saltzman, Executive Chairman and Founder, Defined Health
BREAKOUT 11: TECHNOLOGY
Delivering Precision Medicine with New Digital Technologies
  • Moderator: Jeff Lombardo, PharmD, BCOP, Associate Director, Empire State Patient Safety Assurance Network
  • Faculty:
    • Andrew Norden, CMO, Cota Healthcare
    • Eric Sredzinski, EVP, Clinical and Quality Assurance, Avella Specialty Pharmacy
    • Scooter Plowman, MD, MBA, MHSA, Medical Director, Proteus Digital Health
BREAKOUT 12: SPECIALTY PHARMACY
A Vision for Pharma Value-Based Drug Contracting
  • Moderator: Tom Michaels, SVP, Sales, Vivaleas
  • Faculty:
    • Michael Reff, RPh, MBA, Executive Director & Founder, NCODA
    • Ray Bailey, Director of Pharmacy, Florida Cancer Specialists
    • Matt Farber, Senior Director, Patient Care & Advocacy, Oncology & Fertility, Walgreens
5:00 pm – 6:00 pm Keynote
  • Rowdy Gaines, Three-Time Olympic Gold Medalist and NBC Sports Commentator
  • Rob Butcher, Executive Director, Swim Across America
  • Steve Lundquist, 4-time Olympic Gold Medalist & World-Record Holder
Distinguished Researchers Panel:
  • Moderator: Neil Canavan, Author, A Cure Within
  • Panelists:
    • Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center
    • Luis Diaz, MD, Memorial Sloan Kettering Cancer Center
    • Axel Hoos, MD, President, Oncology, GlaxoSmithKline
6:00 pm – 9:00 pm

Evening Network Reception:
High-Value Auction Event to benefit Swim Across America: Making Waves to Fight Cancer

Book Signing: Neil Canavan, MSc, Author, A Cure Within

Day 2 – Wednesday, October 31, 2018

6:30 am – 7:00 am Networking Breakfast
7:00 am – 7:50 am Oncology Drug Pipeline Overview, Next 3 Years
  • Moderator: Jeffrey Bockman, PhD, EVP, Oncology Practice Head, Defined Health, a Cello Health business
  • Faculty:
    • Michael R. Mong, PharmD, Director, Specialty Pharmacy Development, Walgreen Co.
    • Cheryl Allen, BSPharm, MBA, VP, Industry Relations, Diplomat Pharmacy
7:50 am – 8:00 am Opening Remarks
Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
8:00 am – 9:00 am Oncology Drug Benefits into the Future
  • Moderator: Kevin Cast, Partner, Archbow Consulting
  • Faculty:
    • Everett Neville, RPh, EVP, Strategy, Supply Chain & Specialty, Express Scripts
    • Surya Singh, MD, Corporate VP, Head, Medical Benefit Management, CVS Caremark
    • Scott Reid, PharmD, eviCore Healthcare
    • C. Lyn Fitzgerald, SVP, US & Global Development, National Comprehensive Cancer Network
Track 1:
CLINICAL
Track 2:
TECHNOLOGY
Track 3:
SUPPLY CHAIN
Track 4:
BUSINESS
Track 5:
CONTRACTING
Track 6:
SPECIALTY PHARMACY
Track 7:
CARE MANAGEMENT
Track 8:
INDUSTRY SURVEY
9:00 am – 10:00 am
BREAKOUT 1: SUPPLY CHAIN
Strategies for Delivering on Pharmaceutical Value, a Focus on Quality
  • Moderator: Darin Rubin, CEO, Managing Director, The Dedham Group LLC
  • Faculty:
    • Danielle Ziernicki, BS, RPh, PharmD, National Quality Forum, Steering Committee for Cancer Project, The Dedham Group LLC
    • Ira Klein, MD, MBA, FACP, Senior Director, Healthcare Quality Strategy, J&J Health Care Systems
    • Norris Turner, PharmD, PhD, VP, Strategic Alliances and Measure Implementation, Pharmacy Quality Alliance
BREAKOUT 2: CLINICAL
Biosimilars and Impact on Cancer Care
  • Moderator: Robert Rifkin, MD, Medical Director, Biosimilars, US Oncology Network
  • Faculty:
    • William Yoon, PharmD, MBA, Executive Director & Head, US Medical Managed Markets & Strategic Alliances, Sandoz
    • John Kelton, PharmD, Biosimilars Medical Director, Pfizer
    • Chrys Kokino, Global Commercial Head, Biologics & Insulins, Mylan
    • Chad Pettit, Biosimilars Value and Access, Amgen
BREAKOUT 3: BUSINESS
The Pharma Food Chain—Driver of Inflation or Obstacle to Innovation?
  • Moderator: Bruce Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman
  • Faculty:
    • Richard Evans, Founder and General Manager, SSR LLC
    • Brian DeBusk, CEO & President, DeRoyal; Vice Chair, Lincoln Memorial University; Commissioner, MedPAC
    • Anna Kaltenboeck, Program Director and Senior Health Economist, Center for Health Policy & Outcomes, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center
BREAKOUT 4: CARE MANAGEMENT
Standardized Measurements and Process for Navigating Cancer Care
  • Faculty:
    • Tricia Strusowski, MS, RN, Manager, Oncology Solutions; Chair, AONN+ Evidence into Practice Metrics Subcommittee
    • Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
10:00 am – 11:00 am
From K Street to Wall Street: A Look at Cancer Policy Influence on Markets
  • Moderator: Ipsita Smolinski, MBA, MPH, Managing Director, Capitol Street and McAllister & Quinn
  • Faculty:
    • Lisa Gill, Managing Director, Senior Analyst, Healthcare Technology & Distribution, JPMorgan Securities, Inc
    • PNC Bank (TBA)
    • Geoff Meacham, PhD, Managing Director, Biotech & Pharma Research, Barclays
Radiology
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Michael DeLeo, MD, Chief of Radiology, Southern New Hampshire Medical, Chair and Medical Director, Department of Radiology, Hampshire Medical
    • Raj Singla, MD, CMO, Radiation Therapy, eviCore Healthcare
    • Ilya Gipp, MD, PhD, Oncology Solutions Executive, Philips HealthTech
11:00 am – 12:00 pm
View from Capitol Hill and State Capitals: Public Policy Outlook for Cancer Care
  • Moderator: Lindsay Greenleaf, Director, ADVI Health LLC
  • Faculty:
    • John McManus, President & Founder, The McManus Group
    • Kavita Patel, MD, Brookings Institution
  • State panelists:
    • Anthony Fiori, Managing Director, Manatt Health
    • Kip Piper, MA, FACHE, President, Health Results Group, LLC
Oncology Nurse & Nurse Navigators: Best Kept Secret in Value-Based Care
  • Faculty:
    • Brenda Nevidjon, RN, MSN, FAAN, CEO, Oncology Nursing Society
    • Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer, Senior Director of Strategic Planning & Initiatives, The Lynx Group
12:00 pm – 1:00 pm
Understanding Value Equations: Real-World Applications and Implications
  • Moderator: William McGivney, PhD, Managing Principal, McGivney Global Advisors
  • Faculty:
    • Peter Bach, MD, Director, Center for Health Policy & Outcomes, Memorial Sloan Kettering Cancer Center
    • Anthony V. Coletta, MD, MBA, EVP, and President, Facilitated Health Networks, Independence Health Group
    • Ravinder Dhawan, PhD, VP & Head, Oncology, Center for Observational & Real-World Evidence, Merck
    • Amy Niles, VP, External Relations, Pan Foundation
What Happens to a Cancer Patient, Stays with That Cancer Patient; When Will Physicians Accept Patient-Reported Data Into Their EMRs
  • Moderator: Rick Lee, MHA, Chairman, CancerLife
  • Faculty:
    • Charlie Coltman, Founder, CancerLife
    • Mark Soberman, MD, MBA, FACS, Chief Physician Executive, Monocacy Health Partners
    • Theresa Schmidt, MA, PMP, CSPO, Director, Discern Health
    • Gitesh Patel, Director, Global Business Development, Comprehensive Blood & Cancer Centers (CBCC)
1:00 pm – 2:00 pm
Clinical Decision Support in the Midst of Rapid Scientific Innovation
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Robert J. Green, MD, SVP, Clinical Oncology, Flatiron Health
    • Charles Saunders, CEO, Integra Connect
    • Marcus Neubauer, MD, VP, and Medical Director, Value-Based Reimbursement, McKesson Specialty Health
    • Atul Dhir, MD, DPhil, CEO, New Century Health
Patient Panel
  • Moderator: Jill Pollander, Director of Patient Services, National Organization for Rare Disorders
  • Faculty:
    • Dennis P. Scanlon, PhD, Distinguished Professor of Health Policy & Administration, The Pennslvania State University
    • Bob Tufts, Cancer Survivor and Professor, Yeshiva University
    • Matthew Zachery, CEO, Stupid Cancer
    • Jonny Imerman, Founder, Imerman Angels
2:00 pm – 2:45 pm Keynote
Clifford Hudis, MD, FACP, FASCO, CEO, American Society of Clinical Oncology
2:45 pm – 3:45 pm
BREAKOUT 5: TECHNOLOGY
Blockchain and Use Cases in Cancer Healthcare
  • Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
  • Faculty:
    • Bob Charles, BS, MBA, The GeneriSys Company
    • Jennifer Hinkel, Partner, McGivney Global Advisors
BREAKOUT 6: SPECIALTY PHARMACY
Role of the Specialty Pharmacy in Cancer Care
  • Moderator: Sheila M. Arquette, RPH, Executive Director, National Association of Specialty Pharmacy
  • Faculty:
    • Paul Jardina, President & CEO, Onco360
    • Ray Bailey, Director of Pharmacy, Florida Cancer Specialists
    • Josh Stein, MBA, CEO, AdhereTech
    • Sheila Talty, RPh, MBA, Specialty Pharmacy, Business Development, Yale New Haven Health System
BREAKOUT 7: INDUSTRY SURVEY
Revitalizing Patient Cost-Sharing as a Benefit Control Tool: Results from an Industry Survey
  • Melinda Haren, RN, Senior Director, Access Strategies, Zitter Health Insights
BREAKOUT 8: BUSINESS
How Patient Support Services and Payer Policies Impact Patient Decision-Making, Adherence, and Treatment in Oncology
  • Moderator: Charles Stevens, Global Lead, ICON Access, Commercialisation & Communications/President MediMedia & Complete Healthcare Communications, ICONplc
  • Faculty:
    • Nicole Caswell, Executive Director of Operations, CoPilot Provider Services
    • Edward Hensley, Chief Commercial Officer & Co-Founder, AssistRx
    • Maggie Adamski, Senior Director, Patient Insights and Engagement, ICON
    • Douglas Bock, Partner, Archbow Consulting
3:45 pm – 4:30 pm Future Trends in the Cancer Care Ecosystem
  • Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • Faculty:
    • Brenton Fargnoli, MD, Medical Director, Flatiron Health
    • J. Lance Grady, VP Team Lead, Market Access & Reimbursement, Avalere Health
    • Bruce Gould, MD, Medical Director, Northwest Georgia Oncology Centers, P.C.
4:30 pm – 4:45 pm Closing Remarks

*Agenda is subject to change.

Return to Top